BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28180319)

  • 1. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes.
    Goyal A; Myacheva K; Groß M; Klingenberg M; Duran Arqué B; Diederichs S
    Nucleic Acids Res; 2017 Feb; 45(3):e12. PubMed ID: 28180319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research.
    Zhen S; Li X
    Hum Gene Ther; 2019 Jan; 30(1):3-9. PubMed ID: 30045635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 to Silence Long Non-Coding RNAs.
    Rosenlund IA; Calin GA; Dragomir MP; Knutsen E
    Methods Mol Biol; 2021; 2348():175-187. PubMed ID: 34160807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuning the Expression of Long Noncoding RNA Loci with CRISPR Interference.
    Stojic L
    Methods Mol Biol; 2020; 2161():1-16. PubMed ID: 32681501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Scale Perturbation of Long Noncoding RNA Expression Using CRISPR Interference.
    Liu SJ; Horlbeck MA; Weissman JS; Lim DA
    Methods Mol Biol; 2021; 2254():323-338. PubMed ID: 33326085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrogating lncRNA functions via CRISPR/Cas systems.
    S Zibitt M; Hartford CCR; Lal A
    RNA Biol; 2021 Dec; 18(12):2097-2106. PubMed ID: 33685382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
    Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
    Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired guide RNA CRISPR-Cas9 screening for protein-coding genes and lncRNAs involved in transdifferentiation of human B-cells to macrophages.
    Arnan C; Ullrich S; Pulido-Quetglas C; Nurtdinov R; Esteban A; Blanco-Fernandez J; Aparicio-Prat E; Johnson R; Pérez-Lluch S; Guigó R
    BMC Genomics; 2022 May; 23(1):402. PubMed ID: 35619054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood.
    Joung J; Engreitz JM; Konermann S; Abudayyeh OO; Verdine VK; Aguet F; Gootenberg JS; Sanjana NE; Wright JB; Fulco CP; Tseng YY; Yoon CH; Boehm JS; Lander ES; Zhang F
    Nature; 2017 Aug; 548(7667):343-346. PubMed ID: 28792927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Editing of Long Noncoding RNA Using CRISPR/Cas9 Technology.
    Larter K; Yi B; Xi Y
    Methods Mol Biol; 2021; 2372():169-177. PubMed ID: 34417751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
    Unniyampurath U; Pilankatta R; Krishnan MN
    Int J Mol Sci; 2016 Feb; 17(3):291. PubMed ID: 26927085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference.
    Ghosh S; Tibbit C; Liu JL
    Nucleic Acids Res; 2016 May; 44(9):e84. PubMed ID: 26850642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology.
    Mahato RK; Bhattacharya S; Khullar N; Sidhu IS; Reddy PH; Bhatti GK; Bhatti JS
    J Biotechnol; 2024 Jan; 379():98-119. PubMed ID: 38065367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo CRISPR/Cas9-Based Targeted Disruption and Knockin of a Long Noncoding RNA.
    Cheng X; Peters ST; Pruett-Miller SM; Saunders TL; Joe B
    Methods Mol Biol; 2021; 2254():305-321. PubMed ID: 33326084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region.
    Szafranski P; Karolak JA; Lanza D; Gajęcka M; Heaney J; Stankiewicz P
    Mamm Genome; 2017 Aug; 28(7-8):275-282. PubMed ID: 28405742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual sgRNAs facilitate CRISPR/Cas9-mediated mouse genome targeting.
    Zhou J; Wang J; Shen B; Chen L; Su Y; Yang J; Zhang W; Tian X; Huang X
    FEBS J; 2014 Apr; 281(7):1717-25. PubMed ID: 24494965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers.
    Maruyama R; Yokota T
    Methods Mol Biol; 2020; 2176():49-56. PubMed ID: 32865781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adaptive bacterial immune system CRISPR-Cas and its therapeutic potential.
    Tetsch L
    Med Monatsschr Pharm; 2017 Jan; 40(1):17-23. PubMed ID: 29952526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evx1/Evx1as gene locus regulates anterior-posterior patterning during gastrulation.
    Bell CC; Amaral PP; Kalsbeek A; Magor GW; Gillinder KR; Tangermann P; di Lisio L; Cheetham SW; Gruhl F; Frith J; Tallack MR; Ru KL; Crawford J; Mattick JS; Dinger ME; Perkins AC
    Sci Rep; 2016 May; 6():26657. PubMed ID: 27226347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies.
    Zhang F; Zhang L; Zhang C
    Tumour Biol; 2016 Jan; 37(1):163-75. PubMed ID: 26586396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.